The Many Faces Of mCRPC- Assessing Patient Profiles and Tailoring Treatment in a Changing Landscape

Chairperson:

Manfred Wirth¹

Speakers:

Fred Saad,² Joe O’Sullivan,³ Anders Bjartell,⁴ Wolfgang Loidl⁵

1. University Hospital Carl Gustav Carus Dresden and Technical University of Dresden, Dresden, Germany
2. Centre Hospitalier de l’Université de Montréal, Montréal, Canada
3. Centre for Cancer Research and Cell Biology, Queen’s University Belfast and
Northern Ireland Cancer Centre, Belfast, UK
4. Lund University, Malmö, Sweden
5. St Vincent’s Hospital, Linz, Austria

Disclosure:

Speakers participating in this symposium received honorarium from Bayer Healthcare.

Acknowledgements:

Writing assistance provided by Dr Tabasum Mughal.

Support:

The publication of this article was funded by Bayer Healthcare. The views and opinions expressed are those of the authors and not necessarily of Bayer Healthcare.

Citation:

EMJ Urol. 2014;1[1]:28-32. DOI/10.33590/emjurol/10314856. https://doi.org/10.33590/emjurol/10314856.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.